FDA Investigator Alla Dubrovsky

Alla Dubrovsky has inspections in 2 countries as of 26 Jun 2023. Alla Dubrovsky has collaborated with a combinined 2636 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
26 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America, Costa Rica
A Williams, Acton, Adam S Freeman, Alia Dubrovsky, Alice A Blair, Andrea H Norwood, Andrea P Scott, Andrew B Slarve, Andrew E Kay, Angel K Sandhu, Angela D Wise, Angelica G Aziz, Ashar P Parikh, Ashley A Mutawakkil, Beverly A Gallauresi, Blair, Bradley J Maunder, Camacho, Carl Lee, Carr, Catherine J Laufmann, CDR Rochelle B Young, RPh, MSA, Celeste K Wong, Christine M Parmentier, Christopher Do, Christopher W Buser, Cindy W Lewis, Courtney R Bolton, Cynthia L Ford, Damon A Growl, Daniel C Geffin, Daniel J Lahar, Daniel J Roberts, Daniel Velasquez, Darla R Bracy, Darlene B Almogela, David A Lum, David J Gasparovich, David J Leray, Deborah R Lewis, Debra L Boyd Seale, Dustin P Tran, Dustin R Abaonza, Edna J Hidalgo, Elaine S Chow, Elizabeth A Dakan, Elodie Xtong Lin, Emmanuel O Kerry, Eric W Anderson, Francis J Eng, Frank P Bianco, Gary L Zaharek, Gerald N Mcgirl, DDS, Gina M Hall, Gulshan R Anand, Harjap K Atwal, Harperd, Huy T Pham, Ingrid A Zambrana, Ismael Garibay, Italia Nappi, James A Lane, James C Lee, PharmD, James R Montero, Janice Wai, Jeanne A Young, Jeanne J Thai, Jeffrey M Watson, Jeffrey S Buckser, Jeffrey W Shrifter, DPM, Jennifer L Johnson, Jennifer S King, Joan T Briones, Jocelyn T Ramos, John A Liu, Jolene S Hedgecock, Joseph A Seitz, Joseph Tibay, Juan A Morales, Jude C Dikes, Juliane Kjung Lau, Kacie M Crowther, Karen D Phung, Karla J Gibler, Katlin N Stubbs, Kawshalya Pathiraja, Kellie L Thommes, RN, Kenneth S Boehnen, Keren Arkin, Kevin P Foley, Kimberly L Anderson, Kimberly Lewandowski Walker, Kingj, Kristin M Abaonza, Lance M De Souza, MBA, Larkin R Buckalew, Lawton W Lum, LCDR Jennifer H Rhyu, LCDR Matthew J Morrison, Lea Lakes, Lee, Leongc, Linda Linh T Nguyen, Linda Linhn Adams, Linda S Shook, Liu, Lorna F Jones, Lorraine N Dixon, Lorraine N Williams, LT Mark A Chen, MPH, Lucila B Nwatu, Lydia S Chan, Macropolk, Maida Henesian (NMI), Maridali De Leon Torres, Marie K Kinkade, Marissa J Chan, Mark E Chan, Marlo Ianm Alintanahan, Marlo Ianm Alintanahin, Marshalette O Edwards, Mary C Wall, Mary R Hole, Matthew M Vernon, Michelle L Tripp, Monique C Lo, Nicole Yuen, Nympha V Florendo, Paul M Kawamoto, Phung, Quynh H Strandberg, Randall F Albright, Randall J Plunkett, Raymond T Oji, Roberta K Smith, Ronald P Boyce, Roy Baby, Sandra S Saniga, Sara M Richardson, Sean P Desbrow, Seema S Singh, Sergio Chavez (NMI), Seyyida Saterfield, Siobhan A Gallagher, State Agency, Steven B Chiu, Steven C Himebaugh, Steven M Galvez, Stuart W Russell, Suzanne M Healy, Terrence Gee, Thea C Grome, Thomas N Adjabeng, Timothy C Grome, Vi T Au, Victoria Taylor, Wayne L Jefferson, William J Weis

Alla Dubrovsky's Documents

Publish Date Document Type Title
June, 2011 FDA 483 Clarity Medical Systems Inc - Form 483, 2011-06-30
December, 2013 FDA 483 Prexion, Inc. - Form 483, 2013-12-26
June, 2013 FDA 483 Motion Analysis Corporation - Form 483, 2013-06-06
December, 2014 FDA 483 BioCheck, Inc. - Form 483, 2014-12-12
March, 2009 FDA 483 Abbott Diabetes Care, Inc. - Form 483, 2009-03-13
August, 2015 FDA 483 Miramar Labs, Inc. - Form 483, 2015-08-17
March, 2015 FDA 483 Response Rapid Diagnostics, Division Of Mp Biomedicals, Llc - Form 483R, 2015-03-18
November, 2011 FDA 483 James Consolidated, Inc. - Form 483, 2011-11-17
May, 2010 FDA 483 James Consolidated, Inc. - Form 483, 2010-05-04
May, 2013 FDA 483 Auxogyn Inc. - Form 483, 2013-05-29
March, 2015 EIR Rapid Diagnostics, Division Of Mp Biomedicals, Llc - EIR, 2015-03-02
September, 2015 FDA 483 Skeletal Kinetics, Llc - Form 483, 2015-09-24
May, 2015 FDA 483 Microfit, Inc. - Form 483, 2015-05-27
July, 2010 FDA 483 CoolSystems, Inc. DBA Game Ready - Form 483, 2010-07-01
April, 2012 FDA 483 ABB Optical Group LLC - Form 483, 2012-04-03
March, 2014 EIR Cutera, Inc. - EIR, 2014-03-25
March, 2015 FDA 483 Dream Systems, LLC - Form 483, 2015-03-20
December, 2011 FDA 483 Aqueduct Medical Incorporated - Form 483, 2011-12-07
June, 2015 FDA 483 Cepheid - Form 483, 2015-06-16
June, 2014 FDA 483 AcelRx Pharmaceuticals, Inc. - Form 483, 2014-06-30
November, 2011 FDA 483 Electro-Diagnostic Imaging, Inc. - Form 483, 2011-11-03
March, 2014 FDA 483 Cutera, Inc. - Form 483, 2014-03-25
October, 2012 FDA 483 DSAART, LLC - Form 483, 2012-10-17
November, 2012 FDA 483 Clareblend Inc - Form 483, 2012-11-14
October, 2014 FDA 483 Stryker Corporation - Form 483, 2014-10-08
March, 2015 FDA 483 Rapid Diagnostics, Division Of Mp Biomedicals, Llc - Form 483, 2015-03-02
April, 2015 EIR Bayer Medical SRL - EIR, 2015-04-16

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more